Pharmacogenomics report directly to consumers approved by US FDA
The US FDA has granted 23andMe ( https://www.23andme.com/ ) an authorization to sell Pharmacogenetic testing directly to consumers . But 23 and me must sell it with some special requirements, and consumer must not use this tests on their own to decide a therapy. The consumers must be vigilant at the same time and use this information only in consultation with the expert. A beginning of consumer marketing of Pharmacogenetic testing possibly may be exploited again by several competitors. FDA must also implement certain guidelines and regulations for consumer marketing (that are clearly informed to the consumer by the seller) , especially in relation to genetic material being collected and data that is generated. A milestone that need to be celebrated with care and consideration.